The short answer
The additional bleeding risk from garlic supplements with pentoxifylline is uncertain. Review the exact product and your bleeding risk factors with your prescriber.
What this answer covers
Oral garlic supplements products with oral extended-release pentoxifylline. Exact formulation and clinical setting matter; aspirin, warfarin and other medicines are not interchangeable.
- Supplement or preparation
- Allium sativum
- Medication ingredient
- pentoxifylline
What the original evidence shows
One garlic-tablet study found no significant platelet aggregation change, but menstrual and nasal bleeding were reported. It tested garlic after an aspirin phase and washout, rather than together with a bleeding-risk medicine. The findings raise concern about that product without showing the effect of co-use with pentoxifylline.
Pentoxifylline’s own evidence matters
Bleeding has been reported with pentoxifylline, including in people taking other medicines that affect bleeding. However, a small randomized study in patients with diabetes and coronary disease found no extra platelet inhibition when pentoxifylline was added to aspirin and clopidogrel. This does not exclude rare bleeding, but it limits blanket assumptions about additive effects.
Review the actual supplement
Government guidance cautions about possible bleeding from garlic supplements. Show your pharmacist the daily amount and all ingredients, especially if you also use aspirin or an anticoagulant. Concentrated supplement exposure is different from using garlic as a food ingredient.
Use a monitoring plan, not an untested spacing rule
The label recommends assessment for bleeding in people with risk factors such as recent surgery or ulcer disease. Tell your prescriber about unusual bruising, persistent nosebleeds or other new bleeding; substantial or ongoing bleeding needs prompt care. No supplement-specific hours-apart schedule has been shown to prevent these concerns, and you should not change pentoxifylline yourself.
Evidence and practical considerations
Side effects & toxicity
An increased bleeding rate specifically from garlic supplements with pentoxifylline has not been established.
- Exact scope
- Oral garlic supplements products with oral extended-release pentoxifylline. Exact formulation and clinical setting matter; aspirin, warfarin and other medicines are not interchangeable. with Exact pentoxifylline RxCUI 8013 IN confirmed by current RxNorm. Oral extended-release 400 mg tablets for intermittent claudication; experimental immediate-release, intravenous and other-drug exposures are distinct.
- Medication form and route
- Oral
What remains uncertain
- Available other-drug, short-duration and surrogate-endpoint findings do not quantify this exact pair’s clinical bleeding risk. No validated protective dose separation.
Factors that may matter: Exact preparation and dose; Fasting versus fed dosing; Bleeding and ulcer history; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults with intermittent claudication due to chronic occlusive arterial disease.
Bleeding reported with or without NSAIDs, anticoagulants or platelet inhibitors. Prior methylxanthine intolerance, including caffeine, is a contraindication. Pentoxifylline can raise theophylline levels; strong CYP1A2 inhibitors can raise pentoxifylline exposure.
How this applies: Exact drug/formulation guidance. Exact pentoxifylline RxCUI 8013 IN confirmed by current RxNorm. Oral extended-release 400 mg tablets for intermittent claudication; experimental immediate-release, intravenous and other-drug exposures are distinct.
Does not establish an interaction with every supplement, or transfer theophylline effects to caffeine. Occasional hypotension/arrhythmia reports were not more frequent than placebo in controlled trials. Immediate-release adverse-event results differ from extended-release.
Source 2: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 40 evaluable patients with type 2 diabetes and stable coronary artery disease receiving aspirin and clopidogrel.
No additional inhibition across the measured platelet-function assays.
How this applies: Interpret exact preparation, comparator and endpoint; no automatic combination causality.
Abstract-only; publisher body access failed 403. Short surrogate-endpoint study, no herbs and not proof of absence of rare clinical bleeding.
Source 3: Original clinical research
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 62 healthy adults aged 20-50.
No significant platelet aggregation change, but menstrual and nasal bleeding were reported.
How this applies: Interpret exact preparation, comparator and endpoint; no automatic combination causality.
Open-label single product, inconsistent denominators; no pentoxifylline co-use. No numeric combination risk.
Source 4: Medication terminology
rxnav.nlm.nih.gov · Source check Sep 10, 2026
Population: Terminology.
Pentoxifylline, IN.
How this applies: Exact identity.
Not clinical evidence.
Research assessment: · Open full citations ↗
Side effects & toxicity
Garlic supplements warrant review in pentoxifylline users with other bleeding risks.
- Exact scope
- Oral garlic supplements products with oral extended-release pentoxifylline. Exact formulation and clinical setting matter; aspirin, warfarin and other medicines are not interchangeable. with Exact pentoxifylline RxCUI 8013 IN confirmed by current RxNorm. Oral extended-release 400 mg tablets for intermittent claudication; experimental immediate-release, intravenous and other-drug exposures are distinct.
- Medication form and route
- Oral
What remains uncertain
- Individualized precaution, not proof of increased bleeding with this pair or an automatic need to stop a prescribed regimen.
Factors that may matter: Exact preparation and dose; Fasting versus fed dosing; Bleeding and ulcer history; Other medicines.
Read the supporting source summaries
Source 1: Current prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Adults with intermittent claudication due to chronic occlusive arterial disease.
Bleeding reported with or without NSAIDs, anticoagulants or platelet inhibitors. Prior methylxanthine intolerance, including caffeine, is a contraindication. Pentoxifylline can raise theophylline levels; strong CYP1A2 inhibitors can raise pentoxifylline exposure.
How this applies: Exact drug/formulation guidance. Exact pentoxifylline RxCUI 8013 IN confirmed by current RxNorm. Oral extended-release 400 mg tablets for intermittent claudication; experimental immediate-release, intravenous and other-drug exposures are distinct.
Does not establish an interaction with every supplement, or transfer theophylline effects to caffeine. Occasional hypotension/arrhythmia reports were not more frequent than placebo in controlled trials. Immediate-release adverse-event results differ from extended-release.
Source 2: Government supplement guidance
nccih.nih.gov · Source check Sep 10, 2026
Population: Garlic supplement users.
Warns of possible bleeding risk, especially with medicines affecting bleeding.
How this applies: General supplement precaution plus exact drug context.
No quantified pentoxifylline combination risk.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Sources checked and article drafted. | |
| Research summary published |
Article revision: f3b7b05e01e27a48
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.